Sagittarius Life Science Corp reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 440.46 million compared to TWD 529.07 million a year ago. Net loss was TWD 55.04 million compared to TWD 74.2 million a year ago.

Basic loss per share from continuing operations was TWD 1.69 compared to TWD 2.28 a year ago.